AquaBounty Technologies, Inc. - FDA Lifts Import Alert on AquAdvantage Salmon
09 March 2019 - 7:19AM
AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the
“Company”), a biotechnology company focused on enhancing
productivity in the aquaculture market and a majority-owned
subsidiary of Intrexon Corporation (NASDAQ: XON), announces the
U.S. Food and Drug Administration (FDA) lifting of the Import
Alert, allowing the Company to start farming AquAdvantage Salmon in
Indiana.
Sylvia Wulf, Chief Executive Officer of
AquaBounty, stated: “We are delighted that FDA has lifted the
import alert, which will allow AquaBounty to begin producing and
marketing AquAdvantage Salmon in the United States. As FDA
notes in this announcement, our salmon was approved by the agency
over three years ago based upon a very comprehensive science-based
review process, which established that our salmon was safe,
nutritious, and environmentally sound and met all other regulatory
requirements. We will immediately start the process to import
AquAdvantage eggs from our hatchery in Canada to begin grow out at
our Indiana facility.”
Approximately 350,000 tons of Atlantic salmon
are consumed in the United States with more than 95% of it
imported. FDA’s actions will allow for production and sale to
begin here in the U.S., bringing opportunity for investment in
rural America, creating American jobs, while also reducing
dependence on seafood imports.
The United States has been a world leader in
biotechnology and food innovation, and today’s decision helps to
advance the Company’s leadership in this critical space. This
decision is an important achievement not just for AquaBounty, but
for biotechnology and agricultural innovation in general. As
both FDA and USDA have recognized, animal and plant biotechnology
enable the development of innovative and transformational products
that have the potential to increase sustainable production of food,
enhance human nutrition, and help feed a rapidly growing global
population.
Inquiries:
AquaBounty Technologies,
Inc.Dave Conley, Corporate
Communications +1 613 294
3078
Forward-Looking Statements:
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934,
each as amended. All statements other than statements of historical
fact contained in this press release are forward-looking
statements, including statements regarding the importation of
AquAdvantage Salmon eggs into the United States, the commencement
of production and marketing of AquAdvantage Salmon in the United
States, the potential for benefits to the United States economy,
and the anticipated benefits of biotechnology products, including
AquAdvantage Salmon. Forward-looking statements may be identified
with words such as “will,” “may,” “expect,” “plan,” “anticipate,”
“upcoming,” “believe,” “estimate,” or similar terminology, and the
negative of these terms. Forward-looking statements are not
promises or guarantees of future performance and are subject to a
variety of risks and uncertainties, many of which are beyond our
control, which could cause actual results to differ materially from
those contemplated in these forward-looking statements.
Forward-looking statements speak only as of the date hereof, and,
except as required by law, we undertake no obligation to update or
revise these forward-looking statements. For additional information
regarding these and other risks faced by us, please refer to our
public filings with the Securities and Exchange Commission (“SEC”),
available on the Investors section of our website at
www.aquabounty.com and on the SEC’s website at www.sec.gov.
AquaBounty Technologies (NASDAQ:AQB)
Historical Stock Chart
From Apr 2024 to May 2024
AquaBounty Technologies (NASDAQ:AQB)
Historical Stock Chart
From May 2023 to May 2024